![]()
Neurostimulation and Neuromodulation Device
Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The neurostimulation and neuromodulation device market research reports indicate a growing demand for these devices due to increasing prevalence of neurological disorders. The market is expected to reach a size of $10.5 billion by 2025, driven by technological advancements and a rising aging population. Key players are focused on expanding their product portfolios to capitalize on this growing market.
Request Sample Report
◍ Axogen
◍ Baxter
◍ Boston Scientific
◍ Livanova
◍ Integra Lifesciences
◍ Medtronic
◍ Abbott Laboratories
◍ Stryker
◍ Polyganics
◍ Nuvectra
◍ Neuropace
◍ Orthomed
◍ Nevro
The Neurostimulation and Neuromodulation Device Market is highly competitive, with companies like Medtronic, Boston Scientific, and Abbott Laboratories leading the market. These companies offer a variety of devices for neurological disorders, such as deep brain stimulation, spinal cord stimulation, and vagus nerve stimulation. They help grow the market by developing innovative technologies and expanding their product portfolios.
- Medtronic: $8.92 billion
- Boston Scientific: $2.61 billion
- Abbott Laboratories: $1.45 billion
Request Sample Report
Hospitals and clinics
Ambulatory Surgery Center
Internal
External
Request Sample Report
Request Sample Report
$ X Billion USD